Literature DB >> 6934505

In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells.

R T Turner, J E Puzas, M D Forte, G E Lester, T K Gray, G A Howard, D J Baylink.   

Abstract

The question of whether the skeleton metabolizes 25-hydroxycholecalciferol [25(OH)D3] to more-polar products was studied. Calvarial cells were dispersed from 16-day old chicken embryos by using collagenase and then grown in culture in serum-free medium. Confluent cell cultures were incubated with 7 nM 25(OH)[3H]D3 for 2 hr, and the vitamin D metabolites were then extracted. At least four polar metabolites were produced. Based on separation by Sephadex LH-20 chromatography followed by high-pressure liquid chromatography, two of these metabolites were identified as 1,25-dihydroxycholecalciferol [1,25(OH)2D3] and 24,25-dihydroxycholecalciferol [24,25(OH)2D3]. These metabolites were also produced by cultured kidney cells but not by liver, heart muscle, or skin cells isolated from the same embryos. The specific activities of the calvarial 1- and 24-hydroxylases were similar in magnitude to those in isolated kidney cells. The specific activity of the calvarial 25(OH)D3:1-hydroxylase was inhibited by an 8-hr preincubation with 1,25(OH)2D3, whereas the 24-hydroxylase was enhanced. It is concluded that (i) vitamin D metabolism by isolated cells is organ-specific, (ii) calvarial cells produce active metabolites of vitamin D in significant amounts, (iii) vitamin D metabolism by calvarial cells is regulated by 1,25(OH)2D3, and (iv) locally produced, active metabolites could act locally, thereby adding a new dimension to the regulation of mineral metabolism by vitamin D metabolites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6934505      PMCID: PMC350141          DOI: 10.1073/pnas.77.10.5720

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases.

Authors:  D J Baylink; D J Sherrard; L Shen; N A Maloney; J E Wergedal
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

2.  1,25-dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats.

Authors:  M F Holick; M Garabedian; H F DeLuca
Journal:  Science       Date:  1972-06-09       Impact factor: 47.728

3.  The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats.

Authors:  I T Boyle; L Miravet; R W Gray; M F Holick; H F Deluca
Journal:  Endocrinology       Date:  1972-03       Impact factor: 4.736

4.  Unique biosynthesis by kidney of a biological active vitamin D metabolite.

Authors:  D R Fraser; E Kodicek
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

5.  Quantitative histological studies on the pathogenesis of uremic bone disease.

Authors:  D J Sherrard; D J Baylink; J E Wergedal; N A Maloney
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

6.  Role of vitamin D metabolites in phosphate transport of rat intestine.

Authors:  T C Chen; L Castillo; M Korycka-Dahl; H F DeLuca
Journal:  J Nutr       Date:  1974-08       Impact factor: 4.798

7.  25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties.

Authors:  J C Knutson; H F DeLuca
Journal:  Biochemistry       Date:  1974-03-26       Impact factor: 3.162

8.  Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat.

Authors:  E R Thompson; D J Baylink; J E Wergedal
Journal:  Endocrinology       Date:  1975-08       Impact factor: 4.736

9.  Feedback regulation of vitamin D metabolism by 1,25-dihydroxycholecalciferol.

Authors:  K W Colston; I M Evans; T C Spelsberg; I MacIntyre
Journal:  Biochem J       Date:  1977-04-15       Impact factor: 3.857

10.  Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat.

Authors:  M R Hughes; P F Brumbaugh; M R Hussler; J E Wergedal; D J Baylink
Journal:  Science       Date:  1975-11-07       Impact factor: 47.728

View more
  30 in total

1.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

2.  CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin.

Authors:  Janeen L Vanhooke; Jean M Prahl; Christine Kimmel-Jehan; Monica Mendelsohn; Eric W Danielson; Kevin D Healy; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

3.  Antigenic and catalytic disparity in the distribution of cytochrome P-450-dependent 25-hydroxyvitamin D3-1 alpha- and 24-hydroxylases.

Authors:  K Takezawa; B Moorthy; M L Mandel; J C Garancis; J G Ghazarian
Journal:  Histochemistry       Date:  1990

4.  Transplantation of bone marrow-derived mesenchymal stem cells rescues partially rachitic phenotypes induced by 1,25-Dihydroxyvitamin D deficiency in mice.

Authors:  Zengli Zhang; Shaomeng Yin; Xian Xue; Ji Ji; Jian Tong; David Goltzman; Dengshun Miao
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

5.  In vitro use of vitamin D3 metabolites: culture conditions determine cell uptake.

Authors:  J E Puzas; J S Brand
Journal:  Calcif Tissue Int       Date:  1985-09       Impact factor: 4.333

Review 6.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Extrarenal metabolism of 25-hydroxycholecalciferol in the rat: regulation by 1,25-dihydroxycholecalciferol.

Authors:  R T Turner; R C Avioli; N H Bell
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

Review 8.  Calcitroic Acid-A Review.

Authors:  Olivia B Yu; Leggy A Arnold
Journal:  ACS Chem Biol       Date:  2016-09-06       Impact factor: 5.100

9.  Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination.

Authors:  T D Shultz; J Fox; H Heath; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

10.  Phagocytic cells metabolize 25-hydroxyvitamin D3 in vitro.

Authors:  M S Cohen; T K Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.